Journal
VACCINE
Volume 20, Issue -, Pages B10-B16Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S0264-410X(02)00513-3
Keywords
DNA vaccines; recombinant MV vaccines; polysaccharide-protein conjugates; IRIVs
Categories
Ask authors/readers for more resources
The desire for improved quality of life in both industrialised and under-developed nations has led to the quest for greater understanding and subsequent prevention and treatment of diseases. Here we discuss some of the latest of modem medicine's approaches to vaccination and disease treatment. Our main subject of discussion being the novel antigen delivery systems termed immunopotentiating reconstituted influenza virosomes (IRIVs) and their use as vaccines. Particular attention is paid to the currently licensed Epaxal and Inflexal V, good examples of the improvements being made in vaccinology. Alternative uses of virosomes such as peptide delivery, cytosolic drug delivery and gene delivery are also considered, highlighting the flexibility of the IRIV formulation and method of action. The paper concludes with consideration of alternative novel approaches to vaccinology including bacteria] carriers for DNA vaccines, recombinant MV vaccines and polysaccharide-protein conjugates. (C) 2002 Published by Elsevier Science Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available